[摘要]：We identified a somatic mutation in estrogen receptor-alpha (ER alpha) in breast cancer causing a lysine to arginine transition (K303R) resulting in hypersensitivity to estrogen, altered associations with coactivators and corepressors and altered posttranslational modifications of ER alpha. We have developed a transgenic mouse expressing the K303R mutant ER alpha under control of the mouse mammary tumor virus (MMTV) promoter. At 4 months of age, K303R ER alpha transgenic animals demonstrate precocious alveolar budding compared with wild-type ER alpha transgenic mice or nontransgenic littermates. Despite these morphologic differences, K303R ER alpha transgenic mice displayed no differences in levels of ER alpha, progesterone receptor or proliferation at this time-point. Pregnancy or chronic estrogen plus progesterone exposure in K303R ER alpha transgenic mice also resulted in significantly more alveolar budding, increased beta-casein production and dilated ducts when compared with nontransgenic littermates. To examine the effects of mutant expression on tumorigenesis, mutant ER alpha mice were crossed with FVB-MMTVneu mice and significantly delayed time to neu-mediated tumorigenesis in bigenic animals. In contrast, mutant expression did not affect carcinogen-induced tumorigenesis. Collectively, these data demonstrate that aberrant estrogenic signaling through the K303R ER alpha mutation may lead to precocious alveolar budding in virgin mice, and to an expedited maturation and differentiation phenotype in the mammary glands of hormonally stimulated animals. Oncogene (2009) 28, 3177-3187; doi: 10.1038/onc.2009.174; published online 29 June 2009
